Pulling SEC filings + quote and writing the call…
AMLX
Amylyx Pharmaceuticals, Inc.
Next earnings Aug 5, 2026 · consensus $-0.37 EPS
Last earnings -5.4% on 2026-05-07
$15.91
▲ +1.53%$15.67▲ +188.05%
over 1Y
L $5.02EODHDH $18.36
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+1.5%
1W+12.7%
1M+23.0%
3M+11.5%
YTD+37.2%
1Y+188.1%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 18 analysts
Strong Buy
Conservative balance sheet (liabilities/equity 0.09x); but revenue fell -100.0% YoY.
Amylyx Pharmaceuticals, Inc. shows $0.00 in FY2025 revenue (-100.0% YoY), and -47.4% ROE.
Sources: SEC EDGAR (CIK 0001658551, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 1:52:31 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.